NCT06369259 2026-05-20Open-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Cetuximab in Patients With Unresectable, Anti-EGFR-Refractory Advanced Colorectal CancerM.D. Anderson Cancer CenterPhase 2 Recruiting33 enrolled